Login

TI Ref No :	530968463
Description :	March 19 2026 - FDA Approves Fourth Product Under National Priority Voucher Program Higher Dose Semaglutide
Date :	2026-03-30
Deadline :	0000-00-00
Document Type :	Procurement News